BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24469049)

  • 1. TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.
    Cyr AR; Kulak MV; Park JM; Bogachek MV; Spanheimer PM; Woodfield GW; White-Baer LS; O'Malley YQ; Sugg SL; Olivier AK; Zhang W; Domann FE; Weigel RJ
    Oncogene; 2015 Jan; 34(4):436-44. PubMed ID: 24469049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.
    Park JM; Wu T; Cyr AR; Woodfield GW; De Andrade JP; Spanheimer PM; Li T; Sugg SL; Lal G; Domann FE; Zhang W; Weigel RJ
    Oncogene; 2015 Dec; 34(50):6105-14. PubMed ID: 25772240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFAP2C regulates carbonic anhydrase XII in human breast cancer.
    Franke CM; Gu VW; Grimm BG; Cassady VC; White JR; Weigel RJ; Kulak MV
    Oncogene; 2020 Feb; 39(6):1290-1301. PubMed ID: 31636386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
    De Andrade JP; Park JM; Gu VW; Woodfield GW; Kulak MV; Lorenzen AW; Wu VT; Van Dorin SE; Spanheimer PM; Weigel RJ
    Mol Cancer Ther; 2016 Mar; 15(3):503-11. PubMed ID: 26832794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
    Ghebeh H; Sleiman GM; Manogaran PS; Al-Mazrou A; Barhoush E; Al-Mohanna FH; Tulbah A; Al-Faqeeh K; Adra CN
    BMC Cancer; 2013 Jun; 13():289. PubMed ID: 23768049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells.
    Woodfield GW; Chen Y; Bair TB; Domann FE; Weigel RJ
    Genes Chromosomes Cancer; 2010 Oct; 49(10):948-62. PubMed ID: 20629094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
    Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
    Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.
    Keller PJ; Lin AF; Arendt LM; Klebba I; Jones AD; Rudnick JA; DiMeo TA; Gilmore H; Jefferson DM; Graham RA; Naber SP; Schnitt S; Kuperwasser C
    Breast Cancer Res; 2010; 12(5):R87. PubMed ID: 20964822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.
    Spanheimer PM; Cyr AR; Gillum MP; Woodfield GW; Askeland RW; Weigel RJ
    Ann Surg; 2014 Apr; 259(4):793-9. PubMed ID: 24045439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
    Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer.
    Spanheimer PM; Askeland RW; Kulak MV; Wu T; Weigel RJ
    J Surg Res; 2013 Sep; 184(1):519-25. PubMed ID: 23764310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.
    Liu J; Liu Z; Li M; Tang W; Pratap UP; Luo Y; Altwegg KA; Li X; Zou Y; Zhu H; Sareddy GR; Viswanadhapalli S; Vadlamudi RK
    Mol Oncol; 2021 Apr; 15(4):1146-1161. PubMed ID: 33269540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
    Blick T; Hugo H; Widodo E; Waltham M; Pinto C; Mani SA; Weinberg RA; Neve RM; Lenburg ME; Thompson EW
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):235-52. PubMed ID: 20521089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A
    Wu VT; Kiriazov B; Koch KE; Gu VW; Beck AC; Borcherding N; Li T; Addo P; Wehrspan ZJ; Zhang W; Braun TA; Brown BJ; Band V; Band H; Kulak MV; Weigel RJ
    Mol Cancer Res; 2020 Jan; 18(1):46-56. PubMed ID: 31619506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).
    Oliveras-Ferraros C; Corominas-Faja B; Cufí S; Vazquez-Martin A; Martin-Castillo B; Iglesias JM; López-Bonet E; Martin ÁG; Menendez JA
    Cell Cycle; 2012 Nov; 11(21):4020-32. PubMed ID: 22992620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
    Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.
    Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF
    Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
    Padua MB; Bhat-Nakshatri P; Anjanappa M; Prasad MS; Hao Y; Rao X; Liu S; Wan J; Liu Y; McElyea K; Jacobsen M; Sandusky G; Althouse S; Perkins S; Nakshatri H
    Breast Cancer Res; 2018 May; 20(1):35. PubMed ID: 29720215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.